Second-generation tyrosine kinase inhibitors (Tki) as salvage therapy for resistant or intolerant patients to prior TKIs

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 6, Issue 1, 2014, Pages

  Breccia, Massimo ^a   Alimena, Giuliana ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOSUTINIB; DASATINIB; IMATINIB; NILOTINIB; PONATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADVERSE OUTCOME; ANEMIA; ARTERY THROMBOSIS; BONE MARROW SUPPRESSION; CEREBRAL PALSY; CHRONIC MYELOID LEUKEMIA; CONGESTIVE HEART FAILURE; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DYSPNEA; FATIGUE; FEBRILE NEUTROPENIA; FEVER; HEADACHE; HUMAN; HYPERGLYCEMIA; LEUKOPENIA; MUTATIONAL ANALYSIS; NAUSEA; NAUSEA AND VOMITING; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREATITIS; PERICARDIAL EFFUSION; PERIPHERAL EDEMA; PLEURA EFFUSION; PROGRESSION FREE SURVIVAL; RASH; REVIEW; SALVAGE THERAPY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

EID: 84894041908     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2014.003     Document Type: Article

References (31)

1. Toi PCh, Varghese RG, Rai R. Comparative evaluation of simultaneous bone marrow aspiration and bone marrow biopsy: an institutional experience. Indian J Hematol Blood Transfus. 2010; 26: 41-4. http://dx.doi.org/10.1007/s12288-010-0010-x PMid:21629634 PMCid:PMC3002064
2. Riley RS, Hogan TF, Pavot DR, et al. A pathologist's perspective on bone marrow aspiration and biopsy; Performing a bone marrow examination. J Clin Lab Anal. 2004; 18: 70-9. http://dx.doi.org/10.1002/jcla.20008 PMid:15065211
3. Banys M, Solomayer EF, Becker S et al. Disseminated tumor cells in bone marrow may affect prognosis of patients with gynaecologic malignancies. Int J Gynecol Cancer. 2009; 19: 948-52. http://dx.doi.org/10.1111/IGC.0b013e3181a23c4c PMid:19574790
4. Fend F, Kremer M. Diagnosis and classification of malignant lymphoma and related entities in the bone marrow trephine biopsy. Pathobiology. 2007; 74: 133-43. http://dx.doi.org/10.1159/000101712 PMid:17587884
5. Ozkalemkas F, Ali R, Ozkocaman V et al. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC Cancer. 2005; 5: 144. http://dx.doi.org/10.1186/1471-2407-5-144 PMid:16262899 PMCid:PMC1310632
6. Yuka Y, Yoshihiro N, Koiku Y, Katashi S, Motoomi O. Comparing whole body FDG-PET and bone scan to detect bone metastasis in malignant tumor patients. International Congress Series. 2004; 1264: 239-42. http://dx.doi.org/10.1016/j.ics.2003.12.075
7. Chandra S, Chandra H. Comparison of bone marrow aspirate cytology, touch imprint cytology and trephine biopsy for bone marrow evaluation. Hematol Rep. 2011; 3; e22. PMid:22593814 PMCid:PMC3269795
8. Varma N, Dash S, Sarode R, Marwaha N. Relative efficacy of bone marrow trephine biopsy sections as compared to trephine imprints and aspiration smears in routine hematological practice. Indian J Pathol Microbiol. 1993; 36: 215-26. PMid:8300166
9. Nanda A, Basu S, Marwaha N. Bone marrow trephine biopsy as an adjunct to bone marrow aspiration. J Assoc Physicians India. 2002; 50: 893-5. PMid:12126342
10. Sabharwal BD, Malhotra V, Aruna S, Grewal R. Comparative evaluation of bone marrow aspirate particle smear, imprints and biopsy sections. J Postgrad Med. 1990; 36: 194-8. PMid:2132243
11. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardise response criteria for non-Hodgkin lymphomas. J Clin Oncol. 1999; 17: 1244-53. PMid:10561185
12. Campbell JK, Matthews JP, Seymour JF, Wolf MM, Juneja SK. Australasian Leukaemia Lymphoma Group.Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann Oncol. 2003; 14: 273-6. http://dx.doi.org/10.1093/annonc/mdg055 PMid:12562655
13. Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Hematologica. 2005; 90: 1128-32.
14. Jamshidi K, SwainWR. Bone marrow biopsy with unaltered architecture: a new biopsy device. J Clin Lab Med. 1971; 77: 335-41.
15. Atac B, Lawrence C, Goldberg SN. Metastatic tumor: the complementary role of the marrow aspirate and biopsy. Am J Med Sci. 1991; 302: 211-3. http://dx.doi.org/10.1097/00000441-199110000-00003 PMid:1928232
16. Chandra S, Chandra H, Saini S. Bone marrow metastasis by solid tumors--probable hematological indicators and comparison of bone marrow aspirate, touch imprint and trephine biopsy. Hematology. 2010; 15: 368-72. http://dx.doi.org/10.1179/102453310X12647083621001 PMid:20863433
17. Moid F, Depalma L. Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumour metastasis and Hodgkin Lymphoma. Arch Pathol Lab Med. 2005; 129: 497-501. PMid:15794673
18. Sharma S, Murari M. Bone marrow involvement by metastatic solid tumors. Indian J Pathol Microbiol. 2003; 46: 382-4. PMid:15025279
19. Kumar S, Rau AR, Naik R, et al. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study. Indian J Pathol Microbiol. 2009; 52: 332-8. http://dx.doi.org/10.4103/0377-4929.54987 PMid:19679954
20. Sharma S, Ahuja A, Murari M. Bone marrow biopsy in Hodgkin's disease. Indian J Pathol Microbiol 2004; 47: 364-6 PMid:16295425
21. Franco V, Tripodo C, Rizzo A, Stella M, Florena AM. Bone marrow biopsy in Hodgkin's lymphoma. Eur J Hematol. 2004; 73: 149-55. http://dx.doi.org/10.1111/j.1600-0609.2004.00292.x PMid:15287910
22. Kar R, Dutta S, Tyagi S. Clinically unsuspected Hodgkin's lymphoma diagnosed primarily from bone marrow trephine biopsy: report of six cases. Indian J Pathol Microbiol. 2008; 51: 186-9. http://dx.doi.org/10.4103/0377-4929.41675 PMid:18603677
23. Stifter S, Babarovic E, Valkovic T, et al. Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma Diagnostic Pathology. 2010; 5: 30 http://dx.doi.org/10.1186/1746-1596-5-30 PMid:20482792 PMCid:PMC2883968
24. Brunning R, McKenna RW. : Atlas of tumor pathology. Tumors of the bone marrow Washington, DC: Armed Forces Institute of Pathology, American Registry of Pathology 1994: 323-367.
25. Orazi A. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Pathobiology. 2007; 74: 97-114. http://dx.doi.org/10.1159/000101709 PMid:17587881
26. Vardiman JW, Melo JV, Baccarani M, Thiele J. Chronic myelogenous leukemia, BCR-ABL1 positive. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, eds. WHO classification of tumors of hemtaopoietoic and lymphoid tissues. 4th Ed. Lyon, International Agency for Research on Cancer. 2008; 32-7.
27. Buhr T, Büsche G, Choritz H, Länger F, Kreipe H. Evolution of Myelofibrosis in Chronic Idiopathic Myelofibrosis as Evidenced in Sequential Bone Marrow Biopsy Specimens. Am J Clin Pathol. 2003; 119: 152-8. http://dx.doi.org/10.1309/PTVGB3DXB8A8M7KD PMid:12520711
28. Milosevic R, Jankovic G, Antonijevic N, Jovanovic V, Babic D, Colovic M. Histopathologic characteristics of bone marrow in patients with aplastic anemia. Srp Arh Celok Lek. 2000; 128: 200-4. PMid:11089422
29. Bhargava V, Farhi DC. Bone marrow granulomas, clinicopathological findings in 72 cases and review of the literature. Hematol Pathol. 1988; 2: 43-50. PMid:3069830
30. Bain B. Bone marrow trephine biopsy. J Clin Path. 2001; 54: 737-42. http://dx.doi.org/10.1136/jcp.54.10.737 PMid:11577117
31. Bishop PW, McNally K, Harris M. Audit of bone marrow trephines. J Clin Path. 1992; 45: 1105-8. http://dx.doi.org/10.1136/jcp.45.12.1105 PMid:1479037